Valencia CF and Binartis Genomics reach agreement for disease analysis

Valencia CF have reached an agreement with Binartis Genomics to join the VCF Innovation Hub, offering the club its latest solutions for health and the use of genetics to prevent heart problems and injuries during sports.

Binartis Genomics have more than 20 years of experience in clinical genetics and artificial intelligence. Thanks to these technologies, they undertake exhaustive, reliable genetic analysis at an affordable cost for everyone.

The agreement between Binartis and Valencia CF begins by conducting genetic assessment sessions for the players, followed by genetic analysis of the profiles with the highest risk, under the supervision of the club's medical department. The agreement also includes the holding of talks and training seminars by Binartis at the VCF Academy on the application of genetics in sport. 

CEO and founder of Binartis, Óscar Bastidas, says of the agreement: “Collaborating with Valencia CF is a great opportunity to promote preventive medicine in sports and among the general public. Talking about certain diseases is still taboo for many people in our country, despite them being very present in our families. Facing these conditions before they appear requires courage and changing our habits, and seeing how the Valencia CF players do it proactively is going to be inspiring for a lot of people. Our goal is for everyone to have access to these tests -not just a select few. We want to democratise genetic testing."